Search Results
Mar 28, 2026, 14:39 ET Das Critical Path Institute startet die Initiative „One to Millions", um die Zukunft der personalisierten Medizin weltweit neu zu gestalten
extrem seltenen Erkrankungen mit maßgeschneiderten ASO-Medikamenten zu versorgen. Wir haben mehr als 25 ASOs entdeckt und entwickelt, die es bisher ermöglicht haben, mehr als 45 Patienten mit extrem seltenen Erkrankungen zu behandeln. Viele dieser neuen ASO-Medikamente können zur Behandlung weiterer Patienten
More news about: Critical Path Institute
Mar 27, 2026, 13:25 ET Critical Path Institute spouští iniciativu „Jedna k milionům" s cílem přetvořit budoucnost personalizované medicíny v globálním měřítku
s extrémně vzácnými onemocněními individualizované léky na bázi ASO. Objevili a vyvinuli jsme více než 25 ASO, díky nimž bylo dosud možné léčit více než 45 pacientů s extrémně vzácnými onemocněními. Mnohé z těchto nových léků na bázi ASO lze použít k léčbě dalších pacientů a my jsme odhodláni je k těmto
More news about: Critical Path Institute
Mar 27, 2026, 13:22 ET El Critical Path Institute lanza 'One to Millions' para transformar el futuro de la medicina
escalable para ofrecer medicamentos ASO individualizados a pacientes con enfermedades nanorraras. Hemos descubierto y desarrollado más de 25 ASO que han permitido el tratamiento de más de 45 pacientes con estas enfermedades hasta la fecha. Muchos de estos nuevos medicamentos ASO pueden utilizarse para tratar
More news about: Critical Path Institute
Mar 27, 2026, 13:20 ET Critical Path Institute uruchamia inicjatywę „Od jednego do milionów", aby zmienić przyszłość medycyny spersonalizowanej w skali globalnej
danych, gdzie każde przełomowe odkrycie wspiera kolejne".„W n-Lorem opracowaliśmy solidny i skalowalny proces dostarczania spersonalizowanych leków ASO pacjentom z ultrarzadkimi chorobami. Do tej pory odkryliśmy i opracowaliśmy ponad 25 takich terapii, które umożliwiły leczenie ponad 45 pacjentów. Wiele
More news about: Critical Path Institute
Mar 27, 2026, 13:17 ET Critical Path Institute spúšťa program „One to Millions" - zmena budúcnosti individualizovanej medicíny v globálnom meradle
extrémne zriedkavými ochoreniami poskytovať individualizované lieky ASO. Objavili a vyvinuli sme viac ako 25 ASO, ktoré doteraz umožnili liečbu viac ako 45 pacientov s extrémne zriedkavými ochoreniami. „Mnohé z týchto nových liekov ASO sa dajú využiť na liečbu väčšieho počtu pacientov a my sme odhodlaní
More news about: Critical Path Institute
Mar 27, 2026, 13:15 ET Le Critical Path Institute lance l'initiative « One to Millions » pour redessiner l'avenir de la médecine individualisée à l'échelle mondiale.
évolutif pour apporter des médicaments ASO individualisés à des patients nano-rares. Nous avons découvert et développé plus de 25 oligonucléotides antisens qui ont permis de traiter plus de 45 patients nanorares à ce jour. Beaucoup de ces nouveaux médicaments ASO peuvent être utilisés pour traiter davantage
More news about: Critical Path Institute
Mar 26, 2026, 14:17 ET Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
built a robust and scalable process to bring individualized ASO medicines to nano-rare patients. We have discovered and developed more than 25 ASOs that have enabled treatment of more than 45 nano-rare patients to date. Many of these new ASO medicines can be used to treat more patients and we are committed
More news about: Critical Path Institute
Mar 26, 2026, 14:01 ET Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
built a robust and scalable process to bring individualized ASO medicines to nano-rare patients. We have discovered and developed more than 25 ASOs that have enabled treatment of more than 45 nano-rare patients to date. Many of these new ASO medicines can be used to treat more patients and we are committed
More news about: Critical Path Institute
Mar 23, 2026, 14:54 ET Netenrich Launches Cyber Risk Operations
failures.Netenrich leverages Agentic AI to bridge the gap between risk and operations, accelerating the evolution toward Autonomous Security Operations (ASO) through the Resolution Intelligence Cloud's outcome-driven approach, enabling enterprises to not just feel safe, but to be prepared. Visit our website
More news about: Netenrich
Mar 23, 2026, 09:24 ET PRE Security Unveils Breakthrough Version 3.3 and Earns Top Industry Awards Ahead of RSA Conference 2026
Company introduces SignalGate™ AI data fabric and fully agentic natural language Autonomous Security Operator "ASO;" recognized for Best AI SecOps and Best Cybersecurity Startup by 2026 Cybersecurity Excellence AwardsSAN JOSE, Calif., March
More news about: PRE Security
Mar 20, 2026, 09:05 ET Academy Sports + Outdoors Launches New Tiered myAcademy® Rewards Credit Card and Enhanced Loyalty Program Designed to Help Families Save More and Have More Fun
Academy Sports + Outdoors ("Academy") (Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, today announced the national rollout of the new myAcademy Rewards Mastercard®
More news about: Academy, Ltd. d/b/a Academy Sports + Outdoors
Mar 12, 2026, 09:05 ET Academy Sports + Outdoors Launches Five-Week Work Boot Campaign Championing Access to Trusted Brands and Strong Value
Nasdaq: ASO) is elevating its work boot shopping experience with five weeks of exclusive savings designed for every trade. From Sunday, March 15 to Saturday, April
More news about: Academy, Ltd. d/b/a Academy Sports + Outdoors
Mar 11, 2026, 09:05 ET Academy Sports + Outdoors Increases Year-over-Year Donation to St. Jude Children's Research Hospital® to More Than $575,000
Academy Sports + Outdoors ("Academy") (Nasdaq: ASO) announced an increased year‑over‑year donation of more than $575,000 to
More news about: Academy, Ltd. d/b/a Academy Sports + Outdoors
Mar 10, 2026, 09:05 ET Academy Sports + Outdoors Grows Retail Footprint with Two New Locations in Ohio and Oklahoma
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, is excited to announce it will open two new locations in
More news about: Academy, Ltd. d/b/a Academy Sports + Outdoors
Mar 06, 2026, 09:05 ET Academy Sports + Outdoors Increases Quarterly Cash Dividend
Academy Sports and Outdoors, Inc. (the "Company" or "Academy") (Nasdaq: ASO) announced today that on March 5, 2026, its Board of Directors declared a quarterly cash dividend of $0.15 per share of the Company's common stock with
More news about: Academy, Ltd. d/b/a Academy Sports + Outdoors
Mar 05, 2026, 09:05 ET Celebrate Academy Sports + Outdoors Run Month with Exclusive Deals, Promotions and Gifts for Runners of All Experience Levels
Academy Sports + Outdoors ("Academy" or the "Company") (Nasdaq: ASO) announced today that during Academy Run Month, a month‑long celebration taking place Sunday, March 1, through Tuesday, March 31, it will equip runners
More news about: Academy, Ltd. d/b/a Academy Sports + Outdoors
Mar 05, 2026, 08:00 ET Therna Announces Collaboration with Charles River to Advance Single-Patient Personalized RNA Therapeutics
Lead mRNA program targeting an ultra-rare lung fibrosis and lead ASO program for ultra-rare central nervous system disorderCollaboration unveiled at the Personalized Medicine World ConferenceSAN FRANCISCO,
More news about: Therna Biosciences
Mar 04, 2026, 16:11 ET AppTweak Launches AI Agents to Scale ASO and Apple Ads Performance
marketers the confidence to act quickly on insights they can trust."The launch introduces ASO Agent, Reviews Agent, and Reporting Agent, expanding AppTweak's AI offering across ASO analysis, app store reviews, and performance reporting. It builds on the release of Ad Agent,
More news about: AppTweak
Mar 04, 2026, 09:05 ET Academy Sports + Outdoors Hits It Out of the Park with Grand Slam Deals on Top Youth Baseball, Softball Brands
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, is excited to announce the return of its
More news about: Academy, Ltd. d/b/a Academy Sports + Outdoors
Mar 03, 2026, 09:05 ET Academy Sports + Outdoors Announces Fourth Quarter and Fiscal 2025 Results Conference Call
Nasdaq: ASO), a leading full-line sporting goods and outdoor recreation retailer, plans to release its fourth quarter and fiscal 2025 financial results before the
More news about: Academy, Ltd. d/b/a Academy Sports + Outdoors
Mar 03, 2026, 08:41 ET As AI Agents Replace Search Engines, Capxel Introduces AI Search Optimization -- A New Category of Brand Intelligence
majority of brands are invisible to them."Every company has an SEO strategy. Almost none have an ASO strategy," said Dominick Luna, Co-Founder / President of Capxel, who originated the ASO framework. "The brands that show up when an AI agent answers 'What's the best [product] for [use case]?'
More news about: Capxel
Mar 03, 2026, 07:00 ET SpliSense Granted EMA EARLY PRIME Designation for SPL84 in Cystic Fibrosis
ppFEV1 compared with placebo was 10. These data represent the first evidence of potential clinical benefit for an inhaled antisense oligonucleotide (ASO) therapy in a pulmonary disease.About PRIME designationPRIME is granted to medicines that may offer a major therapeutic advantage
More news about: Splisense
Feb 25, 2026, 08:37 ET Capxel Launches LLM-LD, the First Open Standard for Making Websites Readable by AI Agents
AI Search Optimization (ASO) — a discipline conceived by Co-Founder / President Dominick Luna that focuses on structuring brand content for discoverability by AI agents rather
More news about: Capxel
Feb 24, 2026, 16:10 ET Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results
Performance Suite Lives on Platform are calculated by summing monthly members covered for specialty care services for contracts not under ASO arrangements, plus members managed by Complex Care in capitation arrangements and divided by the number of months in the period. Specialty Technology
More news about: Evolent Health, Inc.
Feb 24, 2026, 08:30 ET Therna Biosciences Appoints Biotech Veteran Devyn Smith, Ph.D., to Board of Directors and Expands Strategic and Scientific Advisory Leadership
stability, immune evasion, and tissue-specific expression. The platform also efficiently identifies optimal target sites within mRNA for maximally effective ASO/siRNA design. Therna's technology allows gene expression to be upregulated, downregulated, or finely tuned, enabling broad applications across a range
More news about: Therna Biosciences